Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2024-02-06 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司关于补选非独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's board of directors. It details the resignation of a non-independent director and the nomination of a new non-independent director, including the nominee's biography and qualifications. There is no financial data, earnings information, or report publication mentioned. The content aligns with announcements about board or management changes.
2024-02-06 Chinese
科美诊断技术股份有限公司监事会关于公司2021年限制性股票激励计划首次授予部分第一个归属期归属名单的核查意见
Regulatory Filings Classification · 90% confidence The document is a verification opinion from the Supervisory Board regarding the first vesting period of a restricted stock incentive plan for the year 2021. It discusses compliance with laws, regulations, and company rules related to stock incentives and the eligibility of incentive recipients. There is no financial data, earnings information, or report publication mentioned. The content focuses on governance and compliance related to stock incentive plans, which aligns with governance or regulatory filings. Given the document's nature and length (909 characters), it is not a full report but a regulatory announcement related to governance matters. Therefore, the best fitting category is Regulatory Filings (RNS).
2024-02-06 Chinese
科美诊断技术股份有限公司2024年第一次临时股东大会资料
AGM Information Classification · 95% confidence The document is titled as the "2024 First Extraordinary General Meeting (EGM) Meeting Materials" of 科美诊断技术股份有限公司. It contains detailed meeting instructions, agenda, and multiple proposals for shareholder approval, including amendments to the company's articles of association, governance rules, and the election of a new non-independent director. The content is typical of materials prepared and distributed for a shareholders' meeting, focusing on governance and voting matters. There is no financial data, earnings information, or audit content. The document is not a report itself but the materials for a shareholders meeting. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings (including extraordinary meetings).
2024-02-06 Chinese
科美诊断技术股份有限公司第二届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the supervisory board of the company regarding resolutions passed in a meeting about adjustments and conditions related to the 2021 restricted stock incentive plan. It includes voting results and references to related announcements published on the stock exchange website. The document is short (1685 characters) and does not contain financial statements or detailed financial data. It is primarily a regulatory announcement about stock incentive plan adjustments and approvals by the supervisory board, not a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance announcement related to corporate governance and stock incentive matters.
2024-02-06 Chinese
科美诊断技术股份有限公司关于召开2024年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2024 first extraordinary general meeting of shareholders, including meeting date, voting methods, agenda items, registration details, and proxy authorization form. It does not contain financial statements or results but is a formal announcement of a shareholders meeting and related procedural information. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is about 5,051 characters, which is consistent with a full meeting notice rather than a brief announcement. There is no indication that this is a voting results declaration or a proxy solicitation document, but rather the meeting notice itself.
2024-02-06 Chinese
科美诊断技术股份有限公司关于以集中竞价交易方式回购公司股份达到总股本1%暨回购进展公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from the company 科美诊断技术股份有限公司 regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total funds used, and references previous announcements about the repurchase plan. The document does not contain financial statements or detailed financial analysis but focuses on the update of the company's own share transactions. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2024-02-05 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.